(MGPI) MGP Ingredients - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55303J1060
Stock: Distilled Spirits, Food Ingredients, Grain Processing
Total Rating 30
Risk 85
Buy Signal -1.65
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -5.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.32 |
| Alpha | -58.86 |
| Character TTM | |
|---|---|
| Beta | 0.578 |
| Beta Downside | 0.438 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.82% |
| CAGR/Max DD | -0.49 |
EPS (Earnings per Share)
Revenue
Description: MGPI MGP Ingredients March 05, 2026
MGP Ingredients, Inc. operates in the distilled spirits and food ingredient sectors, both of which are mature industries with established market dynamics. The company has three segments: Distillery Solutions, Branded Spirits, and Ingredient Solutions.
The Distillery Solutions segment focuses on processing grains into food-grade alcohol for beverages like bourbon and vodka. This segment also provides warehousing and blending services, which are common offerings in the spirits production supply chain.
The Branded Spirits segment encompasses a portfolio of spirits across various price tiers, including bourbons, whiskeys, gins, and tequilas. The company also produces private label products within this segment, a common strategy for expanding market reach in the consumer goods sector.
The Ingredient Solutions segment supplies specialty and commodity wheat-based ingredients, such as starches and proteins, for food applications. This segment also includes gluten-free textured pea and soy proteins, reflecting a growing trend in plant-based food ingredients. Consider exploring ValueRay for detailed financial metrics and segment performance.
Headlines to watch out for
- Whiskey and spirits sales drive revenue growth
- Ingredient solutions segment expands food industry presence
- Grain and energy costs impact distillery margins
- Regulatory changes in alcohol industry pose risk
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -107.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.94 > 1.0 |
| NWC/Revenue: 60.16% < 20% (prev 64.48%; Δ -4.32% < -1%) |
| CFO/TA 0.10 > 3% & CFO 121.5m > Net Income -107.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.4m) vs 12m ago -1.65% < -2% |
| Gross Margin: 37.18% > 18% (prev 0.41%; Δ 3677 % > 0.5%) |
| Asset Turnover: 40.61% > 50% (prev 50.05%; Δ -9.44% > 0%) |
| Interest Coverage Ratio: -13.25 > 6 (EBITDA TTM -75.2m / Interest Expense TTM 7.04m) |
Altman Z'' 3.33
| A: 0.26 (Total Current Assets 522.7m - Total Current Liabilities 200.1m) / Total Assets 1.24b |
| B: 0.36 (Retained Earnings 445.7m / Total Assets 1.24b) |
| C: -0.07 (EBIT TTM -93.3m / Avg Total Assets 1.32b) |
| D: 0.87 (Book Value of Equity 452.1m / Total Liabilities 519.1m) |
| Altman-Z'' Score: 3.33 = A |
Beneish M -3.39
| DSRI: 1.03 (Receivables 119.4m/151.9m, Revenue 536.4m/703.6m) |
| GMI: 1.09 (GM 37.18% / 40.69%) |
| AQI: 0.80 (AQ_t 0.30 / AQ_t-1 0.38) |
| SGI: 0.76 (Revenue 536.4m / 703.6m) |
| TATA: -0.19 (NI -107.8m - CFO 121.5m) / TA 1.24b) |
| Beneish M-Score: -3.39 (Cap -4..+1) = AA |
What is the price of MGPI shares?
As of March 10, 2026, the stock is trading at USD 18.29 with a total of 480,375 shares traded.
Over the past week, the price has changed by -4.59%, over one month by -29.11%, over three months by -25.01% and over the past year by -44.58%.
Over the past week, the price has changed by -4.59%, over one month by -29.11%, over three months by -25.01% and over the past year by -44.58%.
Is MGPI a buy, sell or hold?
MGP Ingredients has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy MGPI.
- StrongBuy: 4
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MGPI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.8 | 57.5% |
| Analysts Target Price | 28.8 | 57.5% |
MGPI Fundamental Data Overview March 08, 2026
P/E Forward = 11.4811
P/S = 0.742
P/B = 0.5564
P/EG = 1.1291
Revenue TTM = 536.4m USD
EBIT TTM = -93.3m USD
EBITDA TTM = -75.2m USD
Long Term Debt = 245.9m USD (from longTermDebt, last quarter)
Short Term Debt = 10.1m USD (from shortTermDebt, last quarter)
Debt = 266.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 248.2m USD (from netDebt column, last quarter)
Enterprise Value = 646.1m USD (398.0m + Debt 266.6m - CCE 18.5m)
Interest Coverage Ratio = -13.25 (Ebit TTM -93.3m / Interest Expense TTM 7.04m)
EV/FCF = 8.50x (Enterprise Value 646.1m / FCF TTM 76.0m)
FCF Yield = 11.77% (FCF TTM 76.0m / Enterprise Value 646.1m)
FCF Margin = 14.18% (FCF TTM 76.0m / Revenue TTM 536.4m)
Net Margin = -20.10% (Net Income TTM -107.8m / Revenue TTM 536.4m)
Gross Margin = 37.18% ((Revenue TTM 536.4m - Cost of Revenue TTM 337.0m) / Revenue TTM)
Gross Margin QoQ = 34.89% (prev 37.76%)
Tobins Q-Ratio = 0.52 (Enterprise Value 646.1m / Total Assets 1.24b)
Interest Expense / Debt = 0.58% (Interest Expense 1.55m / Debt 266.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -73.7m (EBIT -93.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.61 (Total Current Assets 522.7m / Total Current Liabilities 200.1m)
Debt / Equity = 0.37 (Debt 266.6m / totalStockholderEquity, last quarter 716.8m)
Debt / EBITDA = -3.30 (negative EBITDA) (Net Debt 248.2m / EBITDA -75.2m)
Debt / FCF = 3.26 (Net Debt 248.2m / FCF TTM 76.0m)
Total Stockholder Equity = 810.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.16% (Net Income -107.8m / Total Assets 1.24b)
RoE = -13.30% (Net Income TTM -107.8m / Total Stockholder Equity 810.5m)
RoCE = -8.83% (EBIT -93.3m / Capital Employed (Equity 810.5m + L.T.Debt 245.9m))
RoIC = -6.76% (negative operating profit) (NOPAT -73.7m / Invested Capital 1.09b)
WACC = 5.00% (E(398.0m)/V(664.6m) * Re(8.04%) + D(266.6m)/V(664.6m) * Rd(0.58%) * (1-Tc(0.21)))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.59%
[DCF] Terminal Value 88.43% ; FCFF base≈58.1m ; Y1≈71.6m ; Y5≈122.0m
[DCF] Fair Price = 154.7 (EV 3.55b - Net Debt 248.2m = Equity 3.30b / Shares 21.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -41.86 | EPS CAGR: -23.14% | SUE: -0.10 | # QB: 0
Revenue Correlation: -78.65 | Revenue CAGR: -8.78% | SUE: 1.67 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.178 | Chg30d=-0.160 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.59 | Chg7d=-0.854 | Chg30d=-0.964 | Revisions Net=-3 | Growth EPS=-44.3% | Growth Revenue=-9.3%
EPS next Year (2027-12-31): EPS=2.04 | Chg7d=-0.901 | Chg30d=-1.131 | Revisions Net=-3 | Growth EPS=+28.6% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
P/S = 0.742
P/B = 0.5564
P/EG = 1.1291
Revenue TTM = 536.4m USD
EBIT TTM = -93.3m USD
EBITDA TTM = -75.2m USD
Long Term Debt = 245.9m USD (from longTermDebt, last quarter)
Short Term Debt = 10.1m USD (from shortTermDebt, last quarter)
Debt = 266.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 248.2m USD (from netDebt column, last quarter)
Enterprise Value = 646.1m USD (398.0m + Debt 266.6m - CCE 18.5m)
Interest Coverage Ratio = -13.25 (Ebit TTM -93.3m / Interest Expense TTM 7.04m)
EV/FCF = 8.50x (Enterprise Value 646.1m / FCF TTM 76.0m)
FCF Yield = 11.77% (FCF TTM 76.0m / Enterprise Value 646.1m)
FCF Margin = 14.18% (FCF TTM 76.0m / Revenue TTM 536.4m)
Net Margin = -20.10% (Net Income TTM -107.8m / Revenue TTM 536.4m)
Gross Margin = 37.18% ((Revenue TTM 536.4m - Cost of Revenue TTM 337.0m) / Revenue TTM)
Gross Margin QoQ = 34.89% (prev 37.76%)
Tobins Q-Ratio = 0.52 (Enterprise Value 646.1m / Total Assets 1.24b)
Interest Expense / Debt = 0.58% (Interest Expense 1.55m / Debt 266.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -73.7m (EBIT -93.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.61 (Total Current Assets 522.7m / Total Current Liabilities 200.1m)
Debt / Equity = 0.37 (Debt 266.6m / totalStockholderEquity, last quarter 716.8m)
Debt / EBITDA = -3.30 (negative EBITDA) (Net Debt 248.2m / EBITDA -75.2m)
Debt / FCF = 3.26 (Net Debt 248.2m / FCF TTM 76.0m)
Total Stockholder Equity = 810.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.16% (Net Income -107.8m / Total Assets 1.24b)
RoE = -13.30% (Net Income TTM -107.8m / Total Stockholder Equity 810.5m)
RoCE = -8.83% (EBIT -93.3m / Capital Employed (Equity 810.5m + L.T.Debt 245.9m))
RoIC = -6.76% (negative operating profit) (NOPAT -73.7m / Invested Capital 1.09b)
WACC = 5.00% (E(398.0m)/V(664.6m) * Re(8.04%) + D(266.6m)/V(664.6m) * Rd(0.58%) * (1-Tc(0.21)))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.59%
[DCF] Terminal Value 88.43% ; FCFF base≈58.1m ; Y1≈71.6m ; Y5≈122.0m
[DCF] Fair Price = 154.7 (EV 3.55b - Net Debt 248.2m = Equity 3.30b / Shares 21.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -41.86 | EPS CAGR: -23.14% | SUE: -0.10 | # QB: 0
Revenue Correlation: -78.65 | Revenue CAGR: -8.78% | SUE: 1.67 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.178 | Chg30d=-0.160 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.59 | Chg7d=-0.854 | Chg30d=-0.964 | Revisions Net=-3 | Growth EPS=-44.3% | Growth Revenue=-9.3%
EPS next Year (2027-12-31): EPS=2.04 | Chg7d=-0.901 | Chg30d=-1.131 | Revisions Net=-3 | Growth EPS=+28.6% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)